Skip to main content
Top
Published in: Cancer Causes & Control 9/2010

01-09-2010 | Original paper

Disparities in breast cancer prognostic factors by race, insurance status, and education

Authors: Carol DeSantis, Ahmedin Jemal, Elizabeth Ward

Published in: Cancer Causes & Control | Issue 9/2010

Login to get access

Abstract

Black women are more likely to be diagnosed with advanced stage and other less favorable breast cancer prognostic factors than white women. The aim of this study was to examine the extent to which markers of socioeconomic position accounts for black–white differences in these factors. Our study included 193,969 women diagnosed with invasive breast cancers during 2004–2005 from the National Cancer Database, which represents about 72% of all patients with cancer treated in the United States. Compared to white women, black women are more likely to be diagnosed with breast tumors that are less differentiated (odds ratio (OR) = 2.55, 95% confidence interval (CI) 2.44–2.66), hormone receptor negative (OR = 2.29, 95% CI 2.22–2.37), large (OR = 1.87, 95% CI 1.80–1.95), metastatic (OR = 1.89, 95% CI 1.78–2.00), and lymph node-positive (OR = 1.44, 95% CI 1.40–1.48). In multivariable analyses, adjustment for insurance and area-level educational attainment explained 31–39% of the differences in tumor size and metastasis, but only about 14% of the differences in grade and hormone receptors. After accounting for race and other covariates, uninsured women remained 3.66 (95% CI 3.30–4.07) times more likely to have metastasis and 2.37 (95% CI 2.17–2.58) times more likely to have large tumors compared to privately insured women. Similarly, the risk of having breast cancer with less favorable prognostic factors increased as area-level educational attainment decreased. Extending health insurance coverage to all women is likely to have an effect on reducing racial disparities in the development of breast cancers with poor prognostic factors.
Literature
1.
go back to reference Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502CrossRefPubMed Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502CrossRefPubMed
2.
go back to reference Joslyn SA (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 73:45–59CrossRefPubMed Joslyn SA (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 73:45–59CrossRefPubMed
3.
go back to reference Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11:601–607PubMed Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11:601–607PubMed
4.
go back to reference Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86:705–712CrossRefPubMed Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86:705–712CrossRefPubMed
5.
go back to reference Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83:2509–2515CrossRefPubMed Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83:2509–2515CrossRefPubMed
6.
go back to reference Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19:1305–1318CrossRefPubMed Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19:1305–1318CrossRefPubMed
7.
go back to reference Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65CrossRefPubMed Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65CrossRefPubMed
8.
go back to reference Roetzheim RG, Pal N, Tennant C et al (1999) Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409–1415CrossRefPubMed Roetzheim RG, Pal N, Tennant C et al (1999) Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409–1415CrossRefPubMed
9.
go back to reference Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142:796–803PubMed Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142:796–803PubMed
10.
go back to reference Halpern MT, Bian J, Ward EM, Schrag NM, Chen AY (2007) Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer 110:403–411CrossRefPubMed Halpern MT, Bian J, Ward EM, Schrag NM, Chen AY (2007) Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer 110:403–411CrossRefPubMed
11.
go back to reference Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173–2178CrossRefPubMed Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173–2178CrossRefPubMed
12.
go back to reference Hahn KM, Bondy ML, Selvan M et al (2007) Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol 166:1035–1044CrossRefPubMed Hahn KM, Bondy ML, Selvan M et al (2007) Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol 166:1035–1044CrossRefPubMed
13.
go back to reference Bibb SC (2001) The relationship between access and stage at diagnosis of breast cancer in African American and Caucasian women. Oncol Nurs Forum 28:711–719PubMed Bibb SC (2001) The relationship between access and stage at diagnosis of breast cancer in African American and Caucasian women. Oncol Nurs Forum 28:711–719PubMed
14.
go back to reference Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS (1998) Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279:1801–1807CrossRefPubMed Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS (1998) Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279:1801–1807CrossRefPubMed
15.
go back to reference Wells BL, Horm JW (1992) Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health 82:1383–1385CrossRefPubMed Wells BL, Horm JW (1992) Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health 82:1383–1385CrossRefPubMed
16.
go back to reference Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81:646–649CrossRefPubMed Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W (1991) Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 81:646–649CrossRefPubMed
17.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728CrossRefPubMed Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728CrossRefPubMed
18.
go back to reference Krieger N, van den Eeden SK, Zava D, Okamoto A (1997) Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area. Ethn Dis 7:137–149PubMed Krieger N, van den Eeden SK, Zava D, Okamoto A (1997) Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area. Ethn Dis 7:137–149PubMed
19.
go back to reference Chen VW, Correa P, Kurman RJ et al (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3:127–135PubMed Chen VW, Correa P, Kurman RJ et al (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3:127–135PubMed
20.
go back to reference Hunter CP, Redmond CK, Chen VW et al (1993) Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst 85:1129–1137CrossRefPubMed Hunter CP, Redmond CK, Chen VW et al (1993) Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst 85:1129–1137CrossRefPubMed
21.
go back to reference Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMed Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMed
22.
go back to reference Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534–545CrossRefPubMed Miller BA, Hankey BF, Thomas TL (2002) Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534–545CrossRefPubMed
23.
go back to reference Clegg LX, Reichman ME, Miller BA et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20:417–435CrossRefPubMed Clegg LX, Reichman ME, Miller BA et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20:417–435CrossRefPubMed
25.
go back to reference Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97:1528–1540CrossRefPubMed Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97:1528–1540CrossRefPubMed
26.
go back to reference National Center for Health Statistics (2009) Health, United States, 2008 with special feature on the health of young adults. National Center for Health Statistics, Hyattsville, p 349 National Center for Health Statistics (2009) Health, United States, 2008 with special feature on the health of young adults. National Center for Health Statistics, Hyattsville, p 349
27.
go back to reference Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141–148CrossRefPubMed Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141–148CrossRefPubMed
28.
go back to reference Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604CrossRefPubMed Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604CrossRefPubMed
29.
go back to reference DeNavas-Walt C, Proctor BD, Smith JC (2009) Income, poverty, and health insurance coverage in the United States: 2008. US Census Bureau, Current Population Reports, P60–236. U.S. Government Printing Office, Washington, DC DeNavas-Walt C, Proctor BD, Smith JC (2009) Income, poverty, and health insurance coverage in the United States: 2008. US Census Bureau, Current Population Reports, P60–236. U.S. Government Printing Office, Washington, DC
30.
go back to reference Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448CrossRefPubMed Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448CrossRefPubMed
Metadata
Title
Disparities in breast cancer prognostic factors by race, insurance status, and education
Authors
Carol DeSantis
Ahmedin Jemal
Elizabeth Ward
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9572-z

Other articles of this Issue 9/2010

Cancer Causes & Control 9/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine